Panacea Biotech secures order worth Rs 143 crores from UNICEF

Panacea Biotec, a manufacturer of vaccines, announced on Monday that UNICEF and the Pan American Health Organization (PAHO) had awarded it a long-term supply contract worth $127.30 million (roughly INR 1,040 crore) for the supply of its WHO pre-qualified fully liquid pentavalent vaccine, Easyfive-TT (DTwP-HepB-Hib). During the years 2023 through 2027, UNICEF will get a $99 million grant to provide 99.70 million doses, while PAHO will receive a $28.55 million grant to provide 24.83 million doses.

In 2005, Easyfive-TT was introduced in India. Over 150 million doses have been given to more than 75 countries worldwide since getting WHO prequalification in 2008. The vaccination guards kids against Diphtheria, Tetanus, Pertussis, Hepatitis B, and invasive infections brought on by Haemophilus Influenza Type B. These are five terrible illnesses.

Leave a Reply

Shopping Cart
Scroll to Top